Elite Pharmaceuticals (OTCMKTS:ELTP) Announces Quarterly Earnings Results

Elite Pharmaceuticals (OTCMKTS:ELTP) announced its earnings results on Thursday. The specialty pharmaceutical company reported ($0.01) earnings per share for the quarter, Zacks reports. Elite Pharmaceuticals had a negative net margin of 8.98% and a positive return on equity of 15.55%.

Elite Pharmaceuticals Trading Down 4.0 %

OTCMKTS ELTP opened at $0.53 on Friday. The company has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.44. Elite Pharmaceuticals has a 12-month low of $0.12 and a 12-month high of $0.75. The company has a quick ratio of 2.42, a current ratio of 3.52 and a debt-to-equity ratio of 0.10.

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.